CompaniesAngioSense

AngioSense

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

24

By Phase

NA: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT06426134Collaborator

Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS

24 participants

Started: Dec 1, 2024 · Completed: Dec 31, 2025

Related Companies

Microheart

acquired